SHH and cancer: Our data also suggest that, similar to the effects of Shh pathway antagonists [74], systemic cancer therapeutics that block Wnt signaling may cause taste dysfunction, and would need complementary treatment to help restore normal taste function to avoid malnutrition and psychological distress in these patients.